On Monday, 11 December 2017, KEI delivered the following statement in response to WIPO’s publication of a Draft Reference Document on Exception Regarding Acts for Obtaining Regulatory Approval from Authorities. KEI commends the work of the WIPO secretariat in preparing… Continue Reading
On Monday, 11 December 2017, Indonesia, on behalf of the Asia Pacific Group, delivered the following opening statement at the 27th session of the WIPO Standing Committee on the Law of Patents (SCP). The Asia Pacific Group issued a clarion… Continue Reading
For more information, contact: (U.S.) James Love, KEI: james.love@keionline.org or +1 (202) 332-2670 (Chile) Luis Villaroel, Innovarte: info@innovarte.cl or +56 9 9827 9673 Chile FAQ What is happening in Chile with regard to HCV medicines and Xtandi, for prostate cancer?… Continue Reading
FOR IMMEDIATE RELEASE Contact: Kim Treanor kim.treanor@keionline.org; 202-332-2670 Patient groups, civil society and concerned individuals from Chile and around the world call upon President Michelle Bachelet Jeria and Dr. Carmen Castillo Taucher, Minister of Health, to issue a compulsory license… Continue Reading
Attached is the Civil Society input to the 1st World Conference on Access to Medical Products and International Laws for Trade and Health in the context of the 2030 Agenda for Sustainable Development that took place in Delhi, India in… Continue Reading
In a hearing before the House Energy & Commerce Subcommittee on Health, Dr. Francis Collins, Director of the National Institutes of Health, explained the agency’s position on the Bayh-Dole rights and high drug prices. In the hearing, focused on the… Continue Reading
Meeting: EB Special session on the draft Thirteenth General Programme of Work Agenda Item: 3. Draft Thirteenth General Programme of Work Statement: KEI welcomes the opportunity to comment on the 13th General Programme of Work anchored upon WHO’s vision of… Continue Reading
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) Background: The National Institutes of Health has proposed giving an exclusive license for multiple Zika vaccine candidates to PaxVax, a company with close ties to the federal… Continue Reading
Statement by James Love, KEI Director, on GOP proposal to eliminate the Orphan Drug Tax Credit.
The GOP proposal to eliminate the Orphan Drug Tax Credit may create a new opportunity to reform the incentives for rare diseases, even if the tax bill fails or the tax credit survives. The GOP tax bill shows there is weaker support for the existing regime than many thought.
On Friday, 20 October 2017, India delivered the following intervention on compulsory licensing. India briefly recounted the experiences of Brazil, South Africa, and Thailand in using compulsory licensing to secure access to ARVs.